A Report on Non-Ionizing Radiation

Israel: Microwave News Article Archive (2004 - )

October 23, 2017

“Activation of Signaling Cascades by Weak ELF EMFs,” Cellular Physiology and Biochemistry, online October 16, 2017.

Effects seen for exposures to ELF magnetic fields as low as 0.15μT [1.5mG]. Note caveat: These results “cannot be regarded as proof of involvement in cancer, including childhood leukemia.” From the Weizmann Institute in Israel. Open access.

March 6, 2013

“Is Human Saliva an Indicator of the Adverse Health Effects of Using Mobile Phones?” Antioxidants & Redox Signaling, 16, pp.622-627, February 20, 2013:

“[O]ur study indicates that mobile phone users experience considerable oxidative stress on proximal tissue as shown in the saliva, which mostly originates from the parotid glands. Oxidative stress is a potential contributor for the risk for developing cancer…” From the Technion-Israel Institute of Technlogy in Haifa.

January 31, 2012

Olympian’s Brain Tumor Treated with E-Fields

“I am the happiest man alive,” says Robert Dill-Bundi, the Swiss Olympic cycling champion. Dill-Bundi developed a glioblastoma multiforme, an aggressive, usually fatal, type of brain tumor, but is still alive years after being treated with electric fields. The therapy was developed by Novocure, an Israeli company (see: ...

April 18, 2011

FDA OKs E-Field Device To Treat Brain Cancer

A system to treat brain cancer with 100-200 kHz electric fields has been approved by the FDA. The device is made by Novocure. Here is the company's press release announcing the news. And here is a link to a story about the the device, we ran in Microwave News close to four years ago.

January 25, 2011

Cardis and Sadetzki Advise Precaution

"[I]ndications of an increased risk in high- and long-term users [of cell phones] from Interphone and other studies are of concern." This is the conclusion of a commentary, published yesterday in Occupational Environmental Medicine by Elisabeth Cardis and Siegal Sadetzki. Cardis is the head of the ...

"[I]ndications of an increased risk in high- and long-term users [of cell phones] from Interphone and other studies are of concern." This is the conclusion of a commentary, published yesterday in Occupational Environmental Medicine by Elisabeth Cardis and Siegal Sadetzki. Cardis is the head of the Interphone...

June 15, 2007

Weak Kilohertz Electric Fields Kill Tumor Cells

It’s become axiomatic that wide acceptance of non-thermal effects will come from developing biomedical therapies rather than from studying potential hazards. The health effects work is mostly sponsored by those who don't want to find any. And they usually don't (cf: the USAF, EPRI, CTIA, FGF, MMF, etc.) So no one should be surprised that the latest advance comes from a small high-tech Israeli company, Novocure, which is looking for innovative ways to treat cancer. It's a breakthrough —most likely a major breakthrough.

Novocure uses weak 100-200 kHz electric fields —the company calls them tumor treating fields or TTFields— to stunt the growth of cancer cells, either by slowing down their proliferation or by killing them off entirely. The company has now demonstrated this in four different cancer cell lines. Even more impressive is that tumor growth has been curtailed in mice, rats and, in a small pilot project, ten human patients with recurrent brain tumors (glioblastoma).